protein
| interacting with the MADS domain of SRF to coactivate the skeletal alpha-actinin promoter and with MEF2 factors (control of MEF2-dependent muscle-specific gene expression) |
|
interacting with VGLL4 (modulates the activity of TEAD1 factors and counteracts alpha1-adrenergic activation of gene expression in cardiac myocytes) |
|
interact with YAP1 (which lacks a DNA-binding domain but contains an activation domain) to form functional heterodimeric transcription factors that activate proliferative and prosurvival gene expression programs |
|
new, BIRC7-dependent, apoptotic role for TEAD1 |
|
TEAD1 may mediate muscle development through its target genes, MRPL21, NDUFA6 and CCNE1 |
|
regulation of NAIP by TEAD1/YAP1 is at the transcriptional level |
|
TEAD1 is a novel general repressor of smooth muscle-specific gene expression through interfering with MYOCD binding to SRF |
|
CIZ1 enhanced the interaction between YAP1 and TEAD1 |
|
TEAD1 is a novel regulator of PMP22 expression during development in concert with SOX10 and EGR2 |
|
acetylation-mediated, VGLL4-dependent switch that regulates TEAD1 stability and YAP1-TEAD1 activity |
|
VGLL4 negatively regulates the TEAD1-YAP1 transcriptional complex and exerts its growth inhibitory control through its evolutionary conserved TDU2 domain at its C-terminus |
|
NUP37 interacted with YAP1 and activated YAP1/TEAD1 signaling by enhancing the interaction between YAP1 and TEAD1 |
|
YAP1 binds to the TEA domain (TEAD1) transcription factor and controls angiogenesis |
|
TEAD1 overexpression restores AQP4 expression, and both TEAD1 and AQP4 overexpression rescue migratory deficits in TEAD1-knockout cells, implicating a direct regulatory role for TEAD1-AQP4 in glioblastoma (GBM) migration |
|
SLC1A5, a key glutamine transporter, is a novel TEAD1 target gene |
|
transcriptional cofactor VGLL1 plays a prominent role in HPV early gene expression, dependent on its association with the transcription factor TEAD1 |
|
VGLL1 and VGLL3 interact with TEAD1 via a conserved amino acid motif called the TONDU domain |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in hepatocellular carcinoma (HCC), and overexpression is involved in the growth and differentiation of HCC | tumoral
|  
|  
|  
|  
|
suppressed multiple malignant phenotypes of osteosarcoma cells including cell proliferation, apoptosis resistance, and invasive potential | |